Kenneth J Zuerblis - Net Worth and Insider Trading
Kenneth J Zuerblis Net Worth
The estimated net worth of Kenneth J Zuerblis is at least $141,522 dollars as of 2024-11-13. Kenneth J Zuerblis is the Director of Stemline Therapeutics Inc and owns about 11,963 shares of Stemline Therapeutics Inc (STML) stock worth over $141,522. Details can be seen in Kenneth J Zuerblis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth J Zuerblis has not made any transactions after 2014-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth J Zuerblis
Kenneth J Zuerblis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth J Zuerblis owns 4 companies in total, including Stemline Therapeutics Inc (STML) , Immunomedics Inc (IMMU) , and XTL Biopharmaceuticals Ltd (XTLB) among others .
Click here to see the complete history of Kenneth J Zuerblis’s form 4 insider trades.
Insider Ownership Summary of Kenneth J Zuerblis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STML | Stemline Therapeutics Inc | 2020-06-10 | director |
| IMMU | Immunomedics Inc | 2011-12-07 | director |
| XTLB | XTL Biopharmaceuticals Ltd | 2008-10-10 | director |
 | | 2003-06-30 | V.P. & Finance & CFO |
Kenneth J Zuerblis Latest Holdings Summary
Kenneth J Zuerblis currently owns a total of 1 stock. Kenneth J Zuerblis owns 11,963 shares of Stemline Therapeutics Inc (STML) as of September 2, 2014, with a value of $141,522.
Latest Holdings of Kenneth J Zuerblis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STML | Stemline Therapeutics Inc | 2014-09-02 | 11,963 | 11.83 | 141,522 |
Holding Weightings of Kenneth J Zuerblis
Kenneth J Zuerblis Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth J Zuerblis has made a total of 0 transactions in Stemline Therapeutics Inc (STML) over the past 5 years. The most-recent trade in Stemline Therapeutics Inc is the acquisition of 1,000 shares on September 2, 2014, which cost Kenneth J Zuerblis around $11,140.
Insider Trading History of Kenneth J Zuerblis
- 1
Kenneth J Zuerblis Trading Performance
GuruFocus tracks the stock performance after each of Kenneth J Zuerblis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth J Zuerblis is 71.42%. GuruFocus also compares Kenneth J Zuerblis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth J Zuerblis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth J Zuerblis's insider trading performs compared to the benchmark.
Performance of Kenneth J Zuerblis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.19 | | | | | |
| Relative Return to S&P 500(%) | 32.04 | | | | | |
Kenneth J Zuerblis Ownership Network
Ownership Network List of Kenneth J Zuerblis
Ownership Network Relation of Kenneth J Zuerblis
Kenneth J Zuerblis Owned Company Details
What does Stemline Therapeutics Inc do?
Who are the key executives at Stemline Therapeutics Inc?
Kenneth J Zuerblis is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .
Stemline Therapeutics Inc (STML) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stemline Therapeutics Inc Insider Transactions
Kenneth J Zuerblis Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth J Zuerblis. You might contact Kenneth J Zuerblis via mailing address: 20 Kingsbridge Rd, Piscataway Nj 08854.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
